History
Owing to its uniqueness, there was enormous interest in the scientific and medical community with regard to potential applications for many diseases. In addition to offering a full range of microarray analyses for prostate cancer researchers, the facility has established strong collaborations with investigators in the Forestry, Fisheries, Infectious Diseases and the Environmental research communities. In 2001, it was designated as the Genome British Columbia Microarray Platform, under the direction of its founding scientist, Dr. Colleen Nelson. The facility has since served national large-scale genomic projects requiring high capability, expertise and training capacity for the research community. Today, the Microarray Facility is using the latest cutting-edge robotic printers and analytic tools and has developed a variety of microarray services that support small and large projects across Canada and to international collaborators. Our partnership with the scientific community is invaluable and we are thrilled to serve any project with standard or custom needs.
|
 |
|
 |
|
|
|
The
microarray technology group was set up at the Prostate Centre
in 1999 by Dr. Colleen Nelson. At the time of its inception,
the facility was the first in British Columbia and only the
second of its kind in Canada. Using this microarray approach,
the goal was to identify the genes that are critical for the
development and progression of prostate and other cancers. With
information provided by this cutting-edge technology, new diagnostic
and treatment protocols could be designed which are tailored
for the cancers of individual patients.